M. BEKSAÇ Et Al. , "Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma," 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group , vol.41, Florence, Italy, 2008
BEKSAÇ, M. Et Al. 2008. Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma. 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group , (Florence, Italy).
BEKSAÇ, M., Bilgin, A. U., Soydan, E. A., ÖZKOCAMAN, V., Topcuoglu, P., Evranos, B., ... Kizil, M.(2008). Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma . 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, Italy
BEKSAÇ, MERAL Et Al. "Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma," 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, Italy, 2008
BEKSAÇ, MERAL Et Al. "Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma." 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group , Florence, Italy, 2008
BEKSAÇ, M. Et Al. (2008) . "Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma." 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group , Florence, Italy.
@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma}, congress name={34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group}, city={Florence}, country={Italy}, year={2008}}